Institutional investors purchased a net $587.8 thousand shares of ICLR during the quarter ended June 2014 and now own 92.51% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GENEVA INVESTMENT MANAGEMENT OF ... Bought 662.1 Thousand shares of ICON PLC
UBS GLOBAL ASSET MANAGEMENT (AME... Bought 649.9 Thousand shares of ICON PLC